JESSICA SCOTT: Open Payments
NPI 1548609670 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 27 payments from 14 companies in 2025. Trend: 2023 $325 · 2024 $498 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $168 |
| Abbott Laboratories | 1 | $121 |
| Novo Nordisk Inc | 4 | $80 |
| Lilly USA, LLC | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Exact Sciences Corporation | 3 | $64 |
| Amgen Inc. | 2 | $43 |
| Verity Pharmaceuticals Inc. | 1 | $35 |
| ViiV Healthcare Company | 1 | $34 |
| Dexcom, Inc. | 1 | $28 |
Products named: XEN GLAUCOMA TREATMENT SYSTEM, FREESTYLE LIBRE 3, MOUNJARO, LEQVIO, Wegovy, UBRELVY, Tlando, APRETUDE.
Industry payments across CA — which companies pay providers there.
